BJDX MEXC RealStocks
Own real BJDX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-13 15:27:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Bluejay Diagnostics, Inc. (BJDX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $2.64, with a market capitalization of $2.91M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.84 to $28.00. This page covers its latest market performance, valuation, price trends and company information.
$2.91M | |
$2.44 | |
$2.65 | |
$2.39 | |
$2.61 | |
5.09K | |
331.90K | |
-- | |
$28.00 | |
$1.84 | |
-- | |
-- |
Bluejay Diagnostics, Inc. (BJDX) is currently trading at $2.64 as of 2026-11-13 15:25:00, up 8.06% ($0.20) from the previous close of $2.61
During today's regular trading session, BJDX has traded between $2.39 and $2.65, with a trading volume of 5.09K shares. The current price is near the upper end of today's range.
Over the past seven days, Bluejay Diagnostics, Inc. (BJDX) moved from $2.19 to $2.64, representing a gain of 20.59% ($0.45).
The stock traded between $2.10 and $2.90 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 25.16 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 3.1%
BJDX is currently trading at $2.64, placing it 3.1% of the way from its 52-week low of $1.84 to its 52-week high of $28.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 6 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Bluejay Diagnostics, Inc.
Stock Split | |
|---|---|
| Split Date | Nov 3, 2026 |
| Split Ratio | 1-for-4 |
Eligible investors can buy real shares of Bluejay Diagnostics, Inc. (BJDX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to BJDX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between BJDX shares and USD.
BJDX Shares to USD
1.00 BJDX shares = 2.641 USD
Calculations are estimates based on the latest available price and are for reference only.